Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07458477

Digital Audiometer vs. Conventional Audiometer (Gold Standard): Study of Tonal and Vocal Recognition Thresholds

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
52 (estimated)
Sponsor
Centre Hospitalier le Mans · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

According to the WHO (February 2, 2024): More than 5% of the world's population, or 430 million people (including 34 million children), need rehabilitation services due to disabling hearing loss. It is estimated that 700 million people will be affected by 2050, or one in 10 people. It is estimated that by 2050, nearly 2.5 billion people will have some degree of hearing loss. In most cases, audiometric testing involves determining the patient's tonal thresholds and speech recognition thresholds. The Hearing Space device is a digital audiometer that can perform both tonal and speech audiometry. This device stands out because it allows users to calibrate its transducers themselves via a guided, automated procedure. This procedure ensures that the calibration complies with the relevant calibration standards.

Conditions

Interventions

TypeNameDescription
DEVICEHearing Space audiometer first, then AC40 audiometerAll patients will be tested by Hearing Space audiometer first, then AC40 audiometer
DEVICEAC40 audiometer first, then Hearing Space audiometerAll patients will be tested by AC40 audiometer first, then Hearing Space audiometer

Timeline

Start date
2025-11-07
Primary completion
2026-04-07
Completion
2026-04-07
First posted
2026-03-09
Last updated
2026-03-09

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07458477. Inclusion in this directory is not an endorsement.